Herco Medical and Research Center, Inc.
Coral Gables, Florida 33134-2537
2 studies enrolling now · 10 studies all time
What they study most
COVID-19, Cytomegalovirus Infection, Gout, Gout Flare, Hyperuricemia, SARS-CoV-2 Infection, Tophaceous Gout, Tophi
Studies at this site
- A Study of Dotinurad Versus Allopurinol in Tophaceous Gout — Recruiting now
- A Study of Dotinurad Versus Allopurinol in Participants With Gout — Recruiting now
- A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age — Stopped early
- Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — Completed
- Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
- EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
- A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized — Completed
- A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir — Completed
- Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early
- A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed